Home LiteratureArticle Details
PMID: 16766754 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Recent advances in coeliac disease.

Gut ·Vol. 55 ·No. 7 ·2006-07-00 ·Pages 1037-46

van Heel DA, West J

Abstract

暂无摘要

MeSH Terms
Celiac Disease/diagnosis,diet therapy,epidemiology Diagnostic Errors Fertility Humans Incidence Prevalence Risk
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
van Heel D A
Institute of Cell and Molecular Science, Barts and The London, Queen Mary's School of Medicine and Dentistry, Turner St, London E1 2AD, UK. [email protected]
West J
References (125)
125 references, click to expand
  1. Celiac disease and risk of adverse fetal outcome: a population-based cohort study.
    Gastroenterology. 2005 Aug;129(2):454-63 PMID: 16083702
  2. T cells in peripheral blood after gluten challenge in coeliac disease.
    Gut. 2005 Sep;54(9):1217-23 PMID: 16099789
  3. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.
    Gastroenterology. 2005 Sep;129(3):786-96 PMID: 16143118
  4. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.
    Gastroenterology. 2005 Sep;129(3):797-806 PMID: 16143119
  5. Unexpected role of surface transglutaminase type II in celiac disease.
    Gastroenterology. 2005 Nov;129(5):1400-13 PMID: 16285941
  6. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
    Nat Med. 2000 Mar;6(3):337-42 PMID: 10700238
  7. Epidemic of coeliac disease in Swedish children.
    Acta Paediatr. 2000 Feb;89(2):165-71 PMID: 10709885
  8. Incidence and presentation of coeliac disease in South Glamorgan.
    Eur J Gastroenterol Hepatol. 2000 Mar;12(3):345-9 PMID: 10750656
  9. Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening.
    Scand J Gastroenterol. 2000 Apr;35(4):398-402 PMID: 10831263
  10. Endomysial antibody in the diagnosis and management of coeliac disease.
    Postgrad Med J. 2000 Aug;76(898):466-8 PMID: 10908371
  11. A trial of oats in children with newly diagnosed celiac disease.
    J Pediatr. 2000 Sep;137(3):361-6 PMID: 10969261
  12. The clinical impact of metabolic bone disease in coeliac disease.
    Postgrad Med J. 2001 Jan;77(903):33-6 PMID: 11123392
  13. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.
    Gastroenterology. 2001 Feb;120(3):636-51 PMID: 11179241
  14. American Gastroenterological Association medical position statement: Celiac Sprue.
    Gastroenterology. 2001 May;120(6):1522-5 PMID: 11313323
  15. AGA technical review on Celiac Sprue. American Gastroenterological Association.
    Gastroenterology. 2001 May;120(6):1526-40 PMID: 11313324
  16. Coeliac disease and reproductive disorders: a neglected association.
    Eur J Obstet Gynecol Reprod Biol. 2001 Jun;96(2):146-9 PMID: 11384797
  17. Immunologic evidence of no harmful effect of oats in celiac disease.
    Am J Clin Nutr. 2001 Jul;74(1):137-40 PMID: 11451729
  18. High prevalence of celiac disease in Italian general population.
    Dig Dis Sci. 2001 Jul;46(7):1500-5 PMID: 11478502
  19. Mortality in patients with coeliac disease and their relatives: a cohort study.
    Lancet. 2001 Aug 4;358(9279):356-61 PMID: 11502314
  20. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area.
    Am J Gastroenterol. 2001 Sep;96(9):2700-4 PMID: 11569698
  21. High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening?
    Med J Aust. 2001 Sep 3;175(5):247-50 PMID: 11587254
  22. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
    Gastroenterology. 2002 Sep;123(3):803-9 PMID: 12198706
  23. Intestinal digestive resistance of immunodominant gliadin peptides.
    Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G996-G1003 PMID: 12223360
  24. Structural basis for gluten intolerance in celiac sprue.
    Science. 2002 Sep 27;297(5590):2275-9 PMID: 12351792
  25. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis.
    Gastroenterology. 2002 Nov;123(5):1428-35 PMID: 12404215
  26. Anti-tissue transglutaminase antibody as the first line screening for celiac disease: good-bye antigliadin tests?
    Am J Gastroenterol. 2002 Nov;97(11):2702-4 PMID: 12425536
  27. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery.
    Am J Gastroenterol. 2002 Dec;97(12):3160-5 PMID: 12492204
  28. Inflammatory bowel disease in pregnancy.
    Gut. 2003 Feb;52(2):159-61 PMID: 12524388
  29. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.
    Gut. 2003 Feb;52(2):218-23 PMID: 12524403
  30. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.
    Arch Intern Med. 2003 Feb 10;163(3):286-92 PMID: 12578508
  31. Fracture experience of patients with coeliac disease: a population based survey.
    Gut. 2003 Apr;52(4):518-22 PMID: 12631662
  32. Changing presentation of adult celiac disease.
    Dig Dis Sci. 2003 Feb;48(2):395-8 PMID: 12643621
  33. Birth outcomes of women with celiac disease: a nationwide historical cohort study.
    Am J Gastroenterol. 1999 Sep;94(9):2435-40 PMID: 10484005
  34. Gluten contamination of commercial oat products in the United States.
    N Engl J Med. 2004 Nov 4;351(19):2021-2 PMID: 15525734
  35. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy.
    Scand J Gastroenterol. 2004 Nov;39(11):1078-82 PMID: 15545165
  36. Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease.
    Gastroenterology. 2005 Feb;128(2):393-401 PMID: 15685550
  37. Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity.
    Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3599-604 PMID: 15738423
  38. Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2.
    Biochemistry. 2005 Mar 22;44(11):4442-9 PMID: 15766274
  39. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study.
    Gastroenterology. 2005 Apr;128(4):849-55 PMID: 15825068
  40. Dietary guidelines and implementation for celiac disease.
    Gastroenterology. 2005 Apr;128(4 Suppl 1):S121-7 PMID: 15825119
  41. Genetics in coeliac disease.
    Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):323-39 PMID: 15925839
  42. Mortality and causes of death in celiac disease in a Mediterranean area.
    Dig Dis Sci. 1999 Dec;44(12):2538-41 PMID: 10630509
  43. Risk of fractures in celiac disease patients: a cross-sectional, case-control study.
    Am J Gastroenterol. 2000 Jan;95(1):183-9 PMID: 10638580
  44. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.
    Gut. 2000 Jan;46 Suppl 1:i1-8 PMID: 10647595
  45. Coeliac disease and unfavourable outcome of pregnancy.
    Gut. 2000 Mar;46(3):332-5 PMID: 10673293
  46. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    J Exp Med. 2000 Feb 21;191(4):603-12 PMID: 10684852
  47. The risk of stillbirth in pregnancies before and after the onset of diabetes.
    Diabet Med. 2003 Sep;20(9):703-7 PMID: 12925047
  48. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
    Nat Med. 2003 Sep;9(9):1202-8 PMID: 12937416
  49. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.
    Gastroenterology. 2003 Oct;125(4):1105-13 PMID: 14517794
  50. Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
    Gut. 2003 Dec;52(12):1698-702 PMID: 14633945
  51. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study.
    BMJ. 2004 Feb 7;328(7435):322-3 PMID: 14764493
  52. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001.
    Clin Gastroenterol Hepatol. 2003 Jan;1(1):19-27 PMID: 15017513
  53. Stratification of bone fracture risk in patients with celiac disease.
    Clin Gastroenterol Hepatol. 2004 Feb;2(2):127-34 PMID: 15017617
  54. Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire.
    Postgrad Med J. 2002 Jan;78(915):31-3 PMID: 11796869
  55. No harm from five year ingestion of oats in coeliac disease.
    Gut. 2002 Mar;50(3):332-5 PMID: 11839710
  56. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.
    J Exp Med. 2002 Mar 4;195(5):643-9 PMID: 11877487
  57. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
    Am J Gastroenterol. 2002 Mar;97(3):641-8 PMID: 11926208
  58. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.
    Gastroenterology. 2002 Jun;122(7):1729-37 PMID: 12055577
  59. IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease.
    Clin Lab. 2002;48(5-6):241-6 PMID: 12071574
  60. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark.
    Am J Epidemiol. 2002 Jul 1;156(1):1-10 PMID: 12076883
  61. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits.
    J Clin Pathol. 2002 Jul;55(7):488-94 PMID: 12101191
  62. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease.
    Scand J Gastroenterol. 2002 Jun;37(6):685-91 PMID: 12126247
  63. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.
    Hum Immunol. 2003 Apr;64(4):469-77 PMID: 12651074
  64. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England.
    Gut. 2003 Jul;52(7):960-5 PMID: 12801951
  65. Prevalence of Celiac disease among children in Finland.
    N Engl J Med. 2003 Jun 19;348(25):2517-24 PMID: 12815137
  66. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.
    Lancet. 2003 Jul 5;362(9377):30-7 PMID: 12853196
  67. Causes of death in patients with celiac disease in a population-based Swedish cohort.
    Arch Intern Med. 2003 Jul 14;163(13):1566-72 PMID: 12860579
  68. The pathophysiology of bone disease in gastrointestinal disease.
    Eur J Gastroenterol Hepatol. 2003 Aug;15(8):857-64 PMID: 12867794
  69. Fracture risk in people with celiac disease: a population-based cohort study.
    Gastroenterology. 2003 Aug;125(2):429-36 PMID: 12891545
  70. Coeliac disease.
    Lancet. 2003 Aug 2;362(9381):383-91 PMID: 12907013
  71. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.
    Br J Dermatol. 1984 Oct;111(4):395-402 PMID: 6435666
  72. Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland.
    Gastroenterology. 1986 Feb;90(2):334-42 PMID: 3484455
  73. Decreasing incidence of coeliac disease.
    Arch Dis Child. 1987 May;62(5):465-8 PMID: 3606178
  74. Changing pattern of childhood coeliac disease in Finland.
    Acta Paediatr Scand. 1988 May;77(3):408-12 PMID: 3389134
  75. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.
    J Exp Med. 1989 Jan 1;169(1):345-50 PMID: 2909659
  76. Malignancy in coeliac disease--effect of a gluten free diet.
    Gut. 1989 Mar;30(3):333-8 PMID: 2707633
  77. Mortality in celiac disease.
    Gastroenterology. 1989 Aug;97(2):265-71 PMID: 2744350
  78. IgA anti-gliadin antibodies in adult celiac disease.
    Clin Chem. 1991 May;37(5):647-50 PMID: 2032317
  79. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
    J Exp Med. 1993 Jul 1;178(1):187-96 PMID: 8315377
  80. Coeliac disease in the year 2000: exploring the iceberg.
    Lancet. 1994 Jan 22;343(8891):200-3 PMID: 7904667
  81. Wheat peptide challenge in coeliac disease.
    Lancet. 1994 Mar 26;343(8900):758-61 PMID: 7907731
  82. Subclinical coeliac disease: an anthropometric assessment.
    J Intern Med. 1994 Aug;236(2):183-7 PMID: 8046318
  83. A comparison of diets with and without oats in adults with celiac disease.
    N Engl J Med. 1995 Oct 19;333(16):1033-7 PMID: 7675045
  84. Celiac disease and pregnancy outcome.
    Am J Gastroenterol. 1996 Apr;91(4):718-22 PMID: 8677936
  85. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study.
    Acta Paediatr Suppl. 1996 May;412:76-7 PMID: 8783766
  86. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease.
    Bone. 1996 Jun;18(6):525-30 PMID: 8805992
  87. Symptoms and haematologic features in consecutive adult coeliac patients.
    Scand J Gastroenterol. 1996 Jan;31(1):54-60 PMID: 8927941
  88. Incidence and prevalence of adult coeliac disease within a defined geographic area in Denmark.
    Scand J Gastroenterol. 1996 Jul;31(7):694-9 PMID: 8819220
  89. Gynaecological and obstetric disorders in coeliac disease: frequent clinical onset during pregnancy or the puerperium.
    Eur J Gastroenterol Hepatol. 1996 Jan;8(1):63-89 PMID: 8900911
  90. Twenty years of childhood coeliac disease in The Netherlands: a rapidly increasing incidence?
    Gut. 1997 Jan;40(1):61-6 PMID: 9155577
  91. Coeliac disease.
    Lancet. 1997 Jun 14;349(9067):1755-9 PMID: 9193393
  92. Celiac disease and selective immunoglobulin A deficiency.
    J Pediatr. 1997 Aug;131(2):306-8 PMID: 9290622
  93. The smaller size of the 'coeliac iceberg' in adults.
    Scand J Gastroenterol. 1997 Sep;32(9):917-9 PMID: 9299671
  94. Prevalence of coeliac disease in Northern Ireland.
    Lancet. 1997 Nov 8;350(9088):1370 PMID: 9365462
  95. High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach.
    Scand J Gastroenterol. 1997 Nov;32(11):1129-33 PMID: 9399394
  96. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
    Nat Med. 1998 Jun;4(6):713-7 PMID: 9623982
  97. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition.
    Scand J Immunol. 1998 Aug;48(2):111-5 PMID: 9716100
  98. Autoantibodies to tissue transglutaminase as predictors of celiac disease.
    Gastroenterology. 1998 Dec;115(6):1317-21 PMID: 9834256
  99. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease.
    Gastroenterology. 1998 Dec;115(6):1322-8 PMID: 9834257
  100. Coeliac disease in primary care: case finding study.
    BMJ. 1999 Jan 16;318(7177):164-7 PMID: 9888912
  101. Subclinical coeliac disease in schoolchildren from northern Sardinia.
    Lancet. 1999 Jan 2;353(9146):37 PMID: 10023953
  102. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study.
    J Intern Med. 1999 Jan;245(1):63-8 PMID: 10095818
  103. Fortnightly review: coeliac disease.
    BMJ. 1999 Jul 24;319(7204):236-9 PMID: 10417090
  104. Why is coeliac disease endemic in the people of the Sahara?
    Lancet. 1999 Aug 21;354(9179):647-8 PMID: 10466670
  105. Osteopenia in patients with clinically silent coeliac disease warrants screening.
    Lancet. 1999 Aug 28;354(9180):744-5 PMID: 10475193
  106. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.
    Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4175-9 PMID: 15020763
  107. Oats to children with newly diagnosed coeliac disease: a randomised double blind study.
    Gut. 2004 May;53(5):649-54 PMID: 15082581
  108. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.
    J Biol Chem. 2004 Apr 23;279(17):17607-16 PMID: 14747475
  109. A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.
    Gut. 2004 Sep;53(9):1267-73 PMID: 15306583
  110. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.
    Immunity. 2004 Sep;21(3):357-66 PMID: 15357947
  111. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.
    Immunity. 2004 Sep;21(3):367-77 PMID: 15357948
  112. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study.
    Aliment Pharmacol Ther. 2004 Oct 1;20(7):769-75 PMID: 15379837
  113. Malignancy and mortality in people with coeliac disease: population based cohort study.
    BMJ. 2004 Sep 25;329(7468):716-9 PMID: 15269095
  114. Celiac disease and malignancy.
    Medicine (Baltimore). 1980 Jul;59(4):249-61 PMID: 7392945
  115. Childhood coeliac disease is disappearing.
    Lancet. 1980 Dec 20-27;2(8208-8209):1359-60 PMID: 6109168
  116. Childhood coeliac disease is disappearing.
    Lancet. 1981 Feb 7;1(8215):322-3 PMID: 6109952
  117. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79.
    Br Med J (Clin Res Ed). 1983 Jan 8;286(6359):95-7 PMID: 6401509
  118. Coeliac disease in the Rehovot-Ashdod region of Israel: incidence and ethnic distribution.
    J Epidemiol Community Health. 1984 Mar;38(1):58-60 PMID: 6608573
  119. Diagnosis of coeliac disease.
    Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):389-400 PMID: 15925844
  120. Oats induced villous atrophy in coeliac disease.
    Gut. 2003 Nov;52(11):1649-52 PMID: 14570737
  121. The Swedish epidemic of coeliac disease explored using an epidemiological approach--some lessons to be learnt.
    Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):425-40 PMID: 15925847
  122. A systematic approach for comprehensive T-cell epitope discovery using peptide libraries.
    Bioinformatics. 2005 Jun;21 Suppl 1:i29-37 PMID: 15961469
  123. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    N Engl J Med. 2005 Jun 23;352(25):2598-608 PMID: 15972866
  124. The molecular basis for oat intolerance in patients with celiac disease.
    PLoS Med. 2004 Oct;1(1):e1 PMID: 15526039
  125. Immune intervention with anti-CD3 in diabetes.
    Nat Med. 2005 Jul;11(7):716-8 PMID: 16015359
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
DOI
10.1136/gut.2005.075119
Email
[email protected]
Published
2006-07-00
Pages
1037-46
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1856316
Subset
IM
Grants
Wellcome Trust · United Kingdom
Corrections
CommentIn
PMID: 17047123
CommentIn
PMID: 17303611
External Links
PubMed source DOI: 10.1136/gut.2005.075119 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2